What is the address of DR. JOERI STERKEN, anesthesie?

The registered office of DR. JOERI STERKEN, anesthesie is located at Gansbeekstraat 27, 9680 Maarkedal.

Is DR. JOERI STERKEN, anesthesie still active?

Yes. According to the CBE (30 September 2026) DR. JOERI STERKEN, anesthesie is active, legal situation “Normale toestand”, started on 8 February 2008.

Is DR. JOERI STERKEN, anesthesie registered on Peppol?

Yes, DR. JOERI STERKEN, anesthesie is registered on the Peppol network with ID 0208:0895833305.

What is the enterprise number of DR. JOERI STERKEN, anesthesie?

The enterprise number of DR. JOERI STERKEN, anesthesie is BE0895833305.

When was DR. JOERI STERKEN, anesthesie founded?

DR. JOERI STERKEN, anesthesie was founded on 8 February 2008.

Who are the directors of DR. JOERI STERKEN, anesthesie?

According to the 2025 annual accounts, the directors of DR. JOERI STERKEN, anesthesie are: Joeri Sterken.

Is DR. JOERI STERKEN, anesthesie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 February 2008; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. JOERI STERKEN, anesthesie make in 2025?

DR. JOERI STERKEN, anesthesie posted a profit after taxes of € 242,515 in financial year 2025.

What is the revenue of DR. JOERI STERKEN, anesthesie?

As a small company, DR. JOERI STERKEN, anesthesie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 343,720.

DR. JOERI STERKEN, anesthesie (Private Limited)

Dossier DR. JOERI STERKEN, anesthesie, printed on 30 September 2026 from databakkes.be/en/0895833305/dr-joeri-sterken-anesthesie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. JOERI STERKEN, anesthesie from Maarkedal, company number BE0895833305, closed financial year 2025 with a result of € 242,515 after tax. For that financial year DR. JOERI STERKEN, anesthesie recorded a gross margin of € 343,720 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 183,067 to € 242,515. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 21, 2026.

What it is worth Growing

€ 1.2 million

▲ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 242,515

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 655,654

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 56,161 paid out

23 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,180

▲ 169% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,461

▼ 6% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 306,372 Gross margin 2022: € 306,372 First fiscal year in the series	€ 314,059 Gross margin 2023: € 314,059 ▲ 3% vs 2022 (€ 306,372) Favourable step	€ 282,326 Gross margin 2024: € 282,326 ▼ 10% vs 2023 (€ 314,059) Unfavourable step	€ 343,720 Gross margin 2025: € 343,720 ▲ 22% vs 2024 (€ 282,326) Favourable step	▲ 22%
Profit after taxes	€ 204,260 Profit after taxes 2022: € 204,260 First fiscal year in the series	€ 192,874 Profit after taxes 2023: € 192,874 ▼ 6% vs 2022 (€ 204,260) Unfavourable step	€ 183,067 Profit after taxes 2024: € 183,067 ▼ 5% vs 2023 (€ 192,874) Unfavourable step	€ 242,515 Profit after taxes 2025: € 242,515 ▲ 32% vs 2024 (€ 183,067) Favourable step	▲ 32%
Equity	€ 740,398 Equity 2022: € 740,398 First fiscal year in the series	€ 858,478 Equity 2023: € 858,478 ▲ 16% vs 2022 (€ 740,398) Favourable step	€ 984,894 Equity 2024: € 984,894 ▲ 15% vs 2023 (€ 858,478) Favourable step	€ 1,171,249 Equity 2025: € 1,171,249 ▲ 19% vs 2024 (€ 984,894) Favourable step	▲ 19%
Total debts	€ 174,789 Total debts 2022: € 174,789 First fiscal year in the series	€ 117,830 Total debts 2023: € 117,830 ▼ 33% vs 2022 (€ 174,789) Favourable step	€ 165,366 Total debts 2024: € 165,366 ▲ 40% vs 2023 (€ 117,830) Unfavourable step	€ 67,056 Total debts 2025: € 67,056 ▼ 59% vs 2024 (€ 165,366) Favourable step	▼ 59%
Cash	€ 493,807 Cash 2022: € 493,807 First fiscal year in the series	€ 582,667 Cash 2023: € 582,667 ▲ 18% vs 2022 (€ 493,807) Favourable step	€ 780,327 Cash 2024: € 780,327 ▲ 34% vs 2023 (€ 582,667) Favourable step	€ 655,654 Cash 2025: € 655,654 ▼ 16% vs 2024 (€ 780,327) Unfavourable step	▼ 16%
Land & buildings	€ 162,554 Land & buildings 2022: € 162,554 First fiscal year in the series	€ 142,445 Land & buildings 2023: € 142,445 ▼ 12% vs 2022 (€ 162,554) Unchanged	€ 125,095 Land & buildings 2024: € 125,095 ▼ 12% vs 2023 (€ 142,445) Unchanged	€ 110,540 Land & buildings 2025: € 110,540 ▼ 12% vs 2024 (€ 125,095) Unchanged	▼ 12%
Retained profit	€ 727,998 Retained profit 2022: € 727,998 First fiscal year in the series	€ 846,078 Retained profit 2023: € 846,078 ▲ 16% vs 2022 (€ 727,998) Favourable step	€ 972,494 Retained profit 2024: € 972,494 ▲ 15% vs 2023 (€ 846,078) Favourable step	€ 1,158,849 Retained profit 2025: € 1,158,849 ▲ 19% vs 2024 (€ 972,494) Favourable step	▲ 19%
Dividend	€ 121,014 Dividend 2022: € 121,014 First fiscal year in the series	€ 74,794 Dividend 2023: € 74,794 ▼ 38% vs 2022 (€ 121,014) Unchanged	€ 56,652 Dividend 2024: € 56,652 ▼ 24% vs 2023 (€ 74,794) Unchanged	€ 56,161 Dividend 2025: € 56,161 ▼ 1% vs 2024 (€ 56,652) Unchanged	▼ 1%
Bank debt	€ 38,074 Bank debt 2022: € 38,074 First fiscal year in the series	€ 22,001 Bank debt 2023: € 22,001 ▼ 42% vs 2022 (€ 38,074) Favourable step	€ 5,562 Bank debt 2024: € 5,562 ▼ 75% vs 2023 (€ 22,001) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 5,562) Favourable step	▼ 100%
Balance sheet total	€ 915,187 Balance sheet total 2022: € 915,187 First fiscal year in the series	€ 976,308 Balance sheet total 2023: € 976,308 ▲ 7% vs 2022 (€ 915,187) Unchanged	€ 1,150,260 Balance sheet total 2024: € 1,150,260 ▲ 18% vs 2023 (€ 976,308) Unchanged	€ 1,238,305 Balance sheet total 2025: € 1,238,305 ▲ 8% vs 2024 (€ 1,150,260) Unchanged	▲ 8%

Key figures of DR. JOERI STERKEN, anesthesie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DR. JOERI STERKEN, anesthesie?

What happened at DR. JOERI STERKEN, anesthesie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 21, 2026 New annual accounts for financial year 2025: profit of € 242,515 (▲ 32% vs 2024). Source: NBB ↗
Feb 8, 2008 New establishment in Maarkedal. KBO
2008 Joeri Sterken became a director. NBB
Feb 8, 2008 Start of the company according to the CBE. KBO

In short

From € 204,260 profit in 2022 to € 242,515 profit in 2025.

Paid € 400,483 in corporate taxes since 2022.

Best year ever: 2025, with € 242,515 profit.

Paid out € 308,621 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. JOERI STERKEN, anesthesie? We notify you, reason included.

Follow DR. JOERI STERKEN, anesthesie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Joeri Sterken

DR. JOERI STERKEN, anesthesie

Behind DR. JOERI STERKEN, anesthesie is Joeri Sterken.

See the full network in the app

Directors

According to the 2025 annual accounts

Joeri Sterken

Director

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Gansbeekstraat 27

9680 Maarkedal

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0895.833.305
VAT number: BE 0895.833.305
Registered office: Gansbeekstraat 27, 9680 Maarkedal
Names & denominations: DR. JOERI STERKEN, anesthesie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 February 2008
Peppol: Active · Active since 11 Sept 2024
Contact: [email protected] 0486679472

View on CBE Public ↗ Annual accounts (NBB) ↗